Back to Search Start Over

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

Authors :
Christine Stephan
William R. Sellers
Deborah Castelletti
Jeffery A. Porter
Julie L. Bernard
Sandra Mollé
Mark Stump
Tami Hood
Joshua M. Korn
Audrey Kauffmann
Giorgio G. Galli
Kristine Yu
Li Li
Marc Hattenberger
Javad Golji
Zainab Jagani
Marco Wallroth
Tobias Schmelzle
Philippe Megel
Raymond Pagliarini
Rosemary Barrett
Yingzi Yue
Richard S. Eldridge
Jan Weiler
Alberto C. Vitari
Konstantinos J. Mavrakis
Kalyani Gampa
Elizabeth Ackley
Rosalie deBeaumont
Qiong Shen
Joel Berger
Tanja Schouwey
Franklin Chung
E. Robert McDonald
Gregory McAllister
Christelle Stamm
Frances Shanahan
Aurore Desplat
Iris Kao
Thomas A. Perkins
Antoine de Weck
Kavitha Venkatesan
Albert Lai
Jennifer Johnson
Roland Widmer
David A. Ruddy
Avnish Kapoor
Brian Repko
François Gauter
Nicholas Keen
Tanushree Phadke
Eric Billy
Sosathya Sovath
Typhaine Martin
Elizabeth Frias
Justina X. Caushi
Vic E. Myer
Malini Varadarajan
William C. Forrester
Fei Feng
Hans Bitter
Ralph Tiedt
Yue Liu
Jing Zhang
Dorothee Abramowski
Dhiren Belur
Volker M. Stucke
Odile Weber
Mathias Jenal
Ali Farsidjani
Jianjun Yu
Rebecca Billig
JiaJia Feng
A. B. Meyer
Kristen Hurov
Veronica Gibaja
Michael D. Jones
Daisy Flemming
Donald A. Dwoske
Jilin Liu
Clara Delaunay
William Duong
Frank Buxton
Kaitlin J. Macchi
Saskia M. Brachmann
Alice T. Loo
Craig Mickanin
Francesco Hofmann
Frank Stegmeier
Kristy Haas
Gregory R. Hoffman
Marta Cortes-Cros
Roger Caothien
Shumei Liu
Serena J. Silver
Michael R. Schlabach
Emma Lees
Nadire Ramadan
Qiumei Liu
Zhenhai Gao
Source :
Cell. 170:577-592.e10
Publication Year :
2017
Publisher :
Elsevier BV, 2017.

Abstract

Elucidation of the mutational landscape of human cancer has progressed rapidly and been accompanied by the development of therapeutics targeting mutant oncogenes. However, a comprehensive mapping of cancer dependencies has lagged behind and the discovery of therapeutic targets for counteracting tumor suppressor gene loss is needed. To identify vulnerabilities relevant to specific cancer subtypes, we conducted a large-scale RNAi screen in which viability effects of mRNA knockdown were assessed for 7,837 genes using an average of 20 shRNAs per gene in 398 cancer cell lines. We describe findings of this screen, outlining the classes of cancer dependency genes and their relationships to genetic, expression, and lineage features. In addition, we describe robust gene-interaction networks recapitulating both protein complexes and functional cooperation among complexes and pathways. This dataset along with a web portal is provided to the community to assist in the discovery and translation of new therapeutic approaches for cancer.

Details

ISSN :
00928674
Volume :
170
Database :
OpenAIRE
Journal :
Cell
Accession number :
edsair.doi.dedup.....22974eb72276d42f1aa26407b00798f0
Full Text :
https://doi.org/10.1016/j.cell.2017.07.005